QGEN logo

QGEN
Qiagen NV

1,415
Mkt Cap
$7.92B
Volume
1.15M
52W High
$57.82
52W Low
$37.40
PE Ratio
18.79
QGEN Fundamentals
Price
$38.41
Prev Close
$37.97
Open
$37.90
50D MA
$43.10
Beta
0.57
Avg. Volume
2.11M
EPS (Annual)
$2.04
P/B
2.10
Rev/Employee
$369,649.63
$10,556.49
Loading...
Loading...
News
all
press releases
Qiagen Becomes Oversold (QGEN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...
Nasdaq News: Markets·2d ago
News Placeholder
More News
News Placeholder
Qiagen (NYSE:QGEN) Reaches New 52-Week Low - Here's Why
Qiagen (NYSE:QGEN) Sets New 12-Month Low - Here's Why...
MarketBeat·2d ago
News Placeholder
Arcus Biosciences (RCUS) Moves 7.8% Higher: Will This Strength Last?
Arcus Biosciences (RCUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·3d ago
News Placeholder
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026...
Business Wire·9d ago
News Placeholder
Qiagen (NYSE:QGEN) Rating Lowered to "Hold" at Barclays
Barclays cut shares of Qiagen from a "strong-buy" rating to a "hold" rating and set a $44.00 target price on the stock. in a research report on Tuesday...
MarketBeat·10d ago
News Placeholder
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF...
Business Wire·11d ago
News Placeholder
Massachusetts Financial Services Co. MA Increases Stock Position in Qiagen N.V. $QGEN
Massachusetts Financial Services Co. MA lifted its holdings in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 1.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,205,881 shares of the company's...
MarketBeat·14d ago
News Placeholder
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Brokerages
Qiagen N.V. (NYSE:QGEN - Get Free Report) has been assigned an average rating of "Hold" from the twelve research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five ha...
MarketBeat·21d ago
News Placeholder
Allspring Global Investments Holdings LLC Boosts Position in Qiagen N.V. $QGEN
Allspring Global Investments Holdings LLC boosted its position in Qiagen N.V. (NYSE:QGEN - Free Report) by 10.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,164,805 shares of the company's stock after purchasing an additional 290,449 shares du...
MarketBeat·25d ago
News Placeholder
Qiagen (NYSE:QGEN) Cut to "Hold" at Wall Street Zen
Wall Street Zen lowered Qiagen from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·29d ago
<
1
2
...
>

Latest QGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.